Coalition of healthcare industry stakeholders address best practices regarding controlled substances
MOUNT PROSPECT, Ill. — The National Association of Boards of Pharmacy, along with a coalition of healthcare industry stakeholders, on Wednesday issued a consensus statement regarding the collaborative steps that will be taken to help ensure the delivery of responsible and effective patient care as it relates to the prescribing and dispensing of controlled substances.
The agreement indicates the need to work collaboratively to address the prescription drug abuse epidemic and to help practitioners comply with their legal responsibilities for prescribing, dispensing and distributing controlled substances. With the intention of restoring and improving coordination among stakeholders, the 13 participating organizations — which represent physicians, pharmacists, pharmacies, regulatory boards, wholesalers, manufacturers and government agencies — will develop two subsequent consensus documents. The first document will identify the “red flags” that warrant the need to review the legitimacy of controlled substance prescriptions. The second document will outline the actions stakeholder organizations will take to improve dialogue so that such red flags are addressed in compliance with federal and state law, and so that practitioners are supported in delivering the most appropriate patient care.
While some policies recently implemented by stakeholders were intended to protect patients and prevent prescription drug abuse, participants agreed that coordination and collaboration must be improved to ensure that this public health problem is addressed and that patients receive responsible and effective patient care. Additionally, participants recognized that such policies were implemented to help practitioners comply with regulations and were not intended to “intrude into the scopes of practice or authority of other stakeholders.” The forthcoming consensus documents are intended to restore and improve collaboration among all health care practitioners, and to eliminate confusion caused by “the diversity of current proprietary policies.”
“The dialogue and consensus among organizations representing the spectrum of the healthcare team will be instrumental in ensuring that patients with legitimate medical needs receive the most appropriate and safest medication therapy,” said Karen Ryle, president NABP. “By coordinating on actions that help reduce rates of prescription drug abuse, the forthcoming stakeholder discussions and ongoing collaboration will benefit patient care and the public health.”
The consensus document was the result of stakeholder meetings convened by NABP in October 2013 and December 2013. The document was finalized at the December meeting and was developed by NABP and the following organizations: American Academy of Family Physicians, American Medical Association, American Osteopathic Association, Cardinal Health, CVS Caremark, Federation of State Medical Boards, National Association of Chain Drug Stores, National Community Pharmacists Association, Pharmaceutical Care Management Association, Pharmaceutical Research and Manufacturers of America, Rite Aid and Walgreens.
New York’s online database of drug prescriptions curtailing ‘doctor shopping’
ALBANY, N.Y. — The Associated Press on Tuesday reported that New York’s online database of drug prescriptions has curtailed "doctor shopping" by 75%, citing New York Health Commissioner Nirav Shah.
The Internet System for Tracking Over-Prescribing, called I-STOP, began operating in August, AP reported.
According to the report, more than 66,000 practitioners have used it more than 7 million times to check prescriptions on nearly 3 million patients.
Diplomat discusses role of patient advocacy on Pharmacy Podcast
FLINT, Mich. — Diplomat on Wednesday released its second episode in partnership with Pharmacy Podcast. The new installment discusses the role of patient advocacy within the specialty pharmacy field. Diplomat’s manager of patient advocacy, Brenda Hawkes, joins Pharmacy Podcast’s Todd Eury for this conversation.
“Patient advocacy means complete and thorough support of our patients throughout the nation,” Hawkes said. “The goal is to reach out to the advocacy groups and patient support groups that work with the patients who take the medications we fill prescriptions for.”
One notable component of Diplomat’s patient advocacy is outreach at patient support group meetings and conferences. Hawkes and other members of Diplomat’s staff work with patients, caregivers and advocates, regardless of whether or not they utilize Diplomat’s services, to provide information about the various resources for patient assistance that are available to them.
In addition to external efforts, Hawkes is also part of a team inside the company that works to coordinate staff education programs. Diplomat staff members have regular opportunities to learn more about what it is like to live with a serious disease or condition. The added education leads to improved care.
“I’ve always been impressed, [Diplomat is] such a large organization but they haven’t forgot their roots,” stated Eury, “and the patient advocacy is at the heart of it all.”